740 related articles for article (PubMed ID: 33556961)
1. Long-Term Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectiousness Among Three Immunocompromised Patients: From Prolonged Viral Shedding to SARS-CoV-2 Superinfection.
Tarhini H; Recoing A; Bridier-Nahmias A; Rahi M; Lambert C; Martres P; Lucet JC; Rioux C; Bouzid D; Lebourgeois S; Descamps D; Yazdanpanah Y; Le Hingrat Q; Lescure FX; Visseaux B
J Infect Dis; 2021 May; 223(9):1522-1527. PubMed ID: 33556961
[TBL] [Abstract][Full Text] [Related]
2. Prolonged SARS-CoV-2 Positivity in Immunocompetent Patients: Virus Isolation, Genomic Integrity, and Transmission Risk.
Leitão IC; Calil PT; Galliez RM; Moreira FRR; Mariani D; Castiñeiras ACP; da Silva GPD; Maia RA; Corrêa IA; Monteiro FLL; de Souza MRM; Gonçalves CCA; Higa LM; de Jesus Ribeiro L; Fonseca VWP; Bastos VC; Voloch CM; Faffe DS; da Costa Ferreira O; Tanuri A; Castiñeiras TMPP; da Costa LJ;
Microbiol Spectr; 2021 Dec; 9(3):e0085521. PubMed ID: 34787498
[TBL] [Abstract][Full Text] [Related]
3. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea.
Lee S; Kim T; Lee E; Lee C; Kim H; Rhee H; Park SY; Son HJ; Yu S; Park JW; Choo EJ; Park S; Loeb M; Kim TH
JAMA Intern Med; 2020 Nov; 180(11):1447-1452. PubMed ID: 32780793
[TBL] [Abstract][Full Text] [Related]
4. Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19).
Kim DY; Lin MY; Jennings C; Li H; Jung JH; Moore NM; Ghinai I; Black SR; Zaccaro DJ; Brofman J; Hayden MK;
Clin Infect Dis; 2023 Feb; 76(3):e416-e425. PubMed ID: 35607802
[TBL] [Abstract][Full Text] [Related]
5. Prolonged viral shedding of SARS-CoV-2 in two immunocompromised patients, a case report.
Niyonkuru M; Pedersen RM; Assing K; Andersen TE; Skov MN; Johansen IS; Madsen LW
BMC Infect Dis; 2021 Aug; 21(1):743. PubMed ID: 34344321
[TBL] [Abstract][Full Text] [Related]
6. Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture.
Alshukairi AN; Tolah AM; Dada A; Al-Tawfiq JA; Almagharbi RS; Saeedi MF; Al-Hamzi MA; El-Kafrawy SA; Bahaudden HA; El-Saed A; Al-Mozaini MA; Khalid I; Hefni LK; Hassan AM; Alandijany TA; Bajrai LH; Bayumi DT; Albishi GE; Althawadi SI; Zabani NA; Perlman S; Azhar EI
Int J Infect Dis; 2021 Jul; 108():112-115. PubMed ID: 34004329
[TBL] [Abstract][Full Text] [Related]
7. Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.
Nakajima Y; Ogai A; Furukawa K; Arai R; Anan R; Nakano Y; Kurihara Y; Shimizu H; Misaki T; Okabe N
J Infect Chemother; 2021 Feb; 27(2):387-389. PubMed ID: 33328135
[TBL] [Abstract][Full Text] [Related]
8. Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
Owusu D; Pomeroy MA; Lewis NM; Wadhwa A; Yousaf AR; Whitaker B; Dietrich E; Hall AJ; Chu V; Thornburg N; Christensen K; Kiphibane T; Willardson S; Westergaard R; Dasu T; Pray IW; Bhattacharyya S; Dunn A; Tate JE; Kirking HL; Matanock A;
J Infect Dis; 2021 Oct; 224(8):1362-1371. PubMed ID: 33649773
[TBL] [Abstract][Full Text] [Related]
9. Viral Shedding among Re-Positive Severe Acute Respiratory Syndrome Coronavirus-2 Positive Individuals in Republic of Korea.
Kim JM; Ryu B; Choe YJ; Jo HJ; Lee H; Kim HM; Lee NJ; Rhee JE; Chung YS; Han MG; Kim EJ; Park Y; Gwack J; Jin Y; Song J; Seo S; Gill B; Kim H; Park Y; Yoo CK; Jeong EK
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696519
[TBL] [Abstract][Full Text] [Related]
10. Isolation of SARS-CoV-2 in Viral Cell Culture in Immunocompromised Patients With Persistently Positive RT-PCR Results.
Sung A; Bailey AL; Stewart HB; McDonald D; Wallace MA; Peacock K; Miller C; Reske KA; O'Neil CA; Fraser VJ; Diamond MS; Burnham CD; Babcock HM; Kwon JH
Front Cell Infect Microbiol; 2022; 12():804175. PubMed ID: 35186791
[TBL] [Abstract][Full Text] [Related]
11. Prolonged SARS-Cov-2 shedding with rapid IgG antibody decay in a COVID-19 patient: A case report.
Huang J; Lan C; Wang X; Huang M
J Clin Lab Anal; 2021 Nov; 35(11):e24002. PubMed ID: 34528306
[TBL] [Abstract][Full Text] [Related]
12. Diabetes mellitus is a risk factor for prolonged SARS-CoV-2 viral shedding in lower respiratory tract samples of critically ill patients.
Buetti N; Trimboli P; Mazzuchelli T; Lo Priore E; Balmelli C; Trkola A; Conti M; Martinetti G; Elzi L; Ceschi A; Consonni V; Ogna A; Forni-Ogna V; Bernasconi E
Endocrine; 2020 Dec; 70(3):454-460. PubMed ID: 32870469
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in an immunocompromised host: persistent shedding of viable SARS-CoV-2 and emergence of multiple mutations: a case report.
Leung WF; Chorlton S; Tyson J; Al-Rawahi GN; Jassem AN; Prystajecky N; Masud S; Deans GD; Chapman MG; Mirzanejad Y; Murray MCM; Wong PHP
Int J Infect Dis; 2022 Jan; 114():178-182. PubMed ID: 34757008
[TBL] [Abstract][Full Text] [Related]
14. Prolonged SARS-CoV-2 infection following rituximab treatment: clinical course and response to therapeutic interventions correlated with quantitative viral cultures and cycle threshold values.
Thornton CS; Huntley K; Berenger BM; Bristow M; Evans DH; Fonseca K; Franko A; Gillrie MR; Lin YC; Povitz M; Shafey M; Conly JM; Tremblay A
Antimicrob Resist Infect Control; 2022 Feb; 11(1):28. PubMed ID: 35123573
[TBL] [Abstract][Full Text] [Related]
15. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
16. Genomic Evolution of SARS-CoV-2 Virus in Immunocompromised Patient, Ireland.
Lynch M; Macori G; Fanning S; O'Regan E; Hunt E; O'Callaghan D; McCullagh B; Jennings C; Fortune A
Emerg Infect Dis; 2021 Sep; 27(9):2499-2501. PubMed ID: 34161223
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with prolonged viral shedding and impact of lopinavir/ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection.
Yan D; Liu XY; Zhu YN; Huang L; Dan BT; Zhang GJ; Gao YH
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32430428
[TBL] [Abstract][Full Text] [Related]
18. Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
Hirotsu Y; Maejima M; Shibusawa M; Amemiya K; Nagakubo Y; Hosaka K; Sueki H; Hayakawa M; Mochizuki H; Tsutsui T; Kakizaki Y; Miyashita Y; Omata M
J Infect Chemother; 2021 Feb; 27(2):406-409. PubMed ID: 33183963
[TBL] [Abstract][Full Text] [Related]
19. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study.
Hakki S; Zhou J; Jonnerby J; Singanayagam A; Barnett JL; Madon KJ; Koycheva A; Kelly C; Houston H; Nevin S; Fenn J; Kundu R; Crone MA; Pillay TD; Ahmad S; Derqui-Fernandez N; Conibear E; Freemont PS; Taylor GP; Ferguson N; Zambon M; Barclay WS; Dunning J; Lalvani A;
Lancet Respir Med; 2022 Nov; 10(11):1061-1073. PubMed ID: 35988572
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 Genome Variations in Viral Shedding of an Immunocompromised Patient with Non-Hodgkin's Lymphoma.
Villaseñor-Echavarri R; Gomez-Romero L; Martin-Onraet A; Herrera LA; Escobar-Arrazola MA; Ramirez-Vega OA; Barrientos-Flores C; Mendoza-Vargas A; Hidalgo-Miranda A; Vilar-Compte D; Cedro-Tanda A
Viruses; 2023 Jan; 15(2):. PubMed ID: 36851588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
